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Abstract  Acute  necrotizing  pancreatitis  is  a  serious  condition  with  multiple  possible  causes.
In a  proportion  of  patients  it  complicates  with  development  of  necrotic  peripancreatic  collec-
tions and  in  some  cases  these  become  infected.  The  latter  is  a  strong  indication  for  aggressive
treatment,  which  has  classically  been  laparotomy  with  open  necrosectomy.  Surgery  has  major
possible complications  yielding  a  ﬁeld  for  alternative  treatment  options  such  as  endoscopic
drainage and  more  recently  direct  debridement  through  transluminal  oriﬁces.  This  report
describes  interventional  endoscopy  to  treat  two  patients  with  large  peripancreatic  necrotic
and infected  collections,  focusing  on  its  advantages,  limitations  and  future  indications.
© 2011  Sociedade  Portuguesa  de  Gastrenterologia  Published  by  Elsevier  España,  S.L.  All  rights
reserved.
PALAVRAS-CHAVE
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A  crescente  importância  da  endoterapia  na  resoluc¸ão  de  colecc¸ões  pancreáticas
necróticas  organizadas
Resumo  A  pancreatite  aguda  necrotizante  é  uma  patologia  severa  com  múltiplas  etiologias,
que pode  em  algumas  circunstâncias  evoluir  com  a  formac¸ão  de  colecc¸ões  peri-pancreáticas.Endoterapia A ocorrência  de  infecc¸ão  nestas  colecc¸ões  é  um  evento  sério  e  constitui  uma  indicac¸ão  con-
sensual para  tratamento  agressivo.  A  abordagem  terapêutica  clássica  tem  sido,  ao  longo  de
décadas,  a  laparotomia  com  necrosectomia  que,  porém,  apresenta  complicac¸ões  dramáticas  em
muitos doentes.  Por  esta  razão,  têm  surgido  recentemente  técnicas  alternativas  para  resoluc¸ão
destas  lesões  como  a  drenagem  endoscópica  com  desbridamento  de  material  necrótico  através
de orifícios  transluminais.  Os  autores  descrevem  a  aplicac¸ão  das  técnicas  endoscópicas  no
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tratamento  de  duas  doentes  com  colecc¸ões  necróticas  infectadas  volumosas  após  pancreatite
aguda necrotizante.  São  discutidas  as  suas  vantagens,  limitac¸ões  e  indicac¸ões  futuras.
© 2011  Sociedade  Portuguesa  de  Gastrenterologia.  Publicado  por  Elsevier  España,  S.L.  Todos  os
direitos reservados.
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The  development  of  pancreatic  collections  may  occur  in  dif-
ferent  clinical  set-ups.  The  most  frequent  causes  are  acute
or  chronic  pancreatitis,  neoplasms,  surgery  or  trauma.1--3
In  recent  years,  ERCP  has  become  an  important  cause  of
acute  pancreatitis  as  well,  possibly  leading  to  pancreatic
collections  in  more  severe  cases.2,4
Pancreatic  necrosis,  which  is  deﬁned  as  diffuse  or  focal
areas  of  nonviable  pancreatic  parenchyma,  develops  in
nearly  20%  of  patients  and  is  accompanied  with  a  mortality
rate  varying  from  8  to  39%.5,6
Since  1992,  peripancreatic  ﬂuid  collections  have  been
classiﬁed  according  to  the  Atlanta  Criteria  in  order  to
decrease  erroneous  interpretations  previously  made.1,3,6
Additionally  and  for  more  practical  purposes,  pancreatic
ﬂuid  collections  may  also  be  subdivided  into  three  groups:
(a)  acute  pancreatic-ﬂuid  collections;  (b)  pseudocysts;  and
(c)  walled  off  pancreatic  necrosis  (WOPN).  The  latter
was  ﬁrst  used  by  Baron  and  his  co-workers  and  refers  to
the  contained  sterile  or  infected  mature  necrosis  which
may  develop  several  weeks  after  the  acute  inﬂammatory
process.6,7
It  is  crucial  to  distinguish  WOPN  from  the  other  men-
tioned  ﬂuid  collections,  and  most  importantly  the  presence
of  solid  debris  inside  the  collection  since  this  is  critical  to
determine  the  best  therapeutic  proposal.8
There  are  multiple  ways  of  managing  these  collections,
depending  on  their  size,  location,  clinical  symptoms  and
imaging  ﬁndings.1,2,6,8 Accepted  indications  for  drainage
include  chronic  abdominal  pain,  upper  GI  obstruction  (gas-
tric  or  biliary),  intolerance  to  oral  feeding,  signiﬁcant  weight
loss  and  infection.1,2,6 Infected  necrosis  is  virtually  always  an
indication  for  intervention  since  it  is  the  main  determinant
of  multiple  organ  failure  after  necrotizing  pancreatitis.1,4--9
Infection  can  be  suspected  or  conﬁrmed  in  the  presence  of
fever,  increased  inﬂammatory  serum  parameters  (such  as
leucocytosis  or  C-reactive  protein),  positive  bacterial  cul-
tures  of  blood  or  ﬂuid  sample  or  presence  of  gas  inside  the
collection  on  a  CT  scan.1,8
Necrotic  collections  drainage  is  amenable  to  distinct
therapeutic  modalities:  surgery,  endoscopy  or  percuta-
neous  interventional  radiology.  Although  surgery  has  been
regarded  as  the  most  deﬁnitive  and  standard  treatment
procedure,  it  is  also  well  recognized  that  it  carries  high
mortality  (6--39%)  and  considerable  morbidity  (19--69%)
rates.5,8,10For  the  past  15  years,  in  selected  cases,  endoscopic
transluminal  drainage  with  complete  removal  of  infected
necrotic  tissue  has  been  considered  an  alternative  option
to  surgery.  Results  have  been  very  promising  and  it  has
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ﬂeen  consistently  regarded  to  be  as  proﬁcuous  as  surgery
n  controlling  infection  while  being  less  invasive.1,4,6--8
his  technique  was  pioneered  by  Baron  and  colleagues7
sing  stents  and  gastrocystic  vigorous  lavage  through  a
asocystic  catheter.  Few  years  later,  Seifert9 ﬁrst  described
n  unprecedented  direct  retroperitoneal  endoscopic  necro-
ectomy,  changing  since  then  the  course  of  endotherapy.
his  procedure  may  be  accomplished  by  passing  Roth-nets,
nares,  Dormia  baskets  or  even  the  endoscope  itself  through
he  transmural  entry  site  into  the  necrotic-containing  cav-
ty.  These  innovations  set  the  path  for  the  advent  of  natural
riﬁce  transluminal  endoscopic  surgery  (NOTES).1,4--6,8--10
esolution  of  necrotic  infected  collections  improves  with
his  strategy  and  has  been  reported  to  reach  81--93%
ith  over  12-month  follow-up  periods.1,4,8
Case  1:  A  30-year-old  female  was  sent  to  our  department
fter  an  episode  of  severe  acute  lithiasic  pancreatitis  three
onths  earlier.  Her  current  medication  was  oral  pancreatic
nzymes.
The  patient  had  been  complaining,  for  the  previous
eeks,  of  diffuse  abdominal  discomfort,  occasional  vomit-
ng,  progressive  intolerance  to  oral  feeding  and  weight  loss.
he  had  not  noticed  fever  during  this  period.
Laboratory  data  were  as  follows:  haemoglobin  11.9  g/dL;
eucocytes  4.6  × 103/L,  platelets  320  ×  103/L,  INR  1.11,
UN  3  mg/dL,  creatinine  0.57  mg/dL,  alanine  aminotrans-
erase  11  U/L,  aspartate  aminotransferase  15  U/L,  alkaline
hosphatase  112  U/L,  gamma-glutamyltransferase  24  U/L,
otal  bilirubin  0.3  mg/dL,  lactate  dehydrogenase  161  U/L,
erum  amylase  320  U/L,  C-reactive  protein  10.3  mg/dL.
A  contrast  enhanced  computed  tomography  (CECT)  scan
ocumented  a  large  abdominal  peripancreatic  ﬂuid  collec-
ion  with  relatively  well-demarcated  borders,  with  9  cm  of
reater  diameter,  inside  of  which  semi-solid  debris  were
een  (Fig.  1a  ).  The  pancreatic  duct  appeared  slightly  dilated
4  mm)  in  its  distal  segment.  A  magnetic  resonance  sup-
orted  these  ﬁndings.
Percutaneous  CT-guided  drainage  had  been  unsuccessful.
The  patient  agreed  to  undergo  a  transluminal  endoscopic
rainage  of  the  peripancreatic  collection  under  deep  seda-
ion.  On  endoscopy,  a  bulging  lesion  was  evident  on  the
reater  curvature  of  the  gastric  body  thus  allowing  direct
pening  with  a  pre-cut  needle  knife  (Wilson-Cook  Medical
nc.®)  and  introduction  of  a  standard  0.035-in.  guidewire
Olympus®)  followed  by  injection  of  contrast  with  opaciﬁ-
ation  of  the  collection.  Gastrocystic  communication  was
ilated  with  a  standard  balloon  (Olympus®)  up  to  10  mm
Fig.  1b).  A  brown  thick  liquid  with  some  solid  yellow
ebris  started  to  come  out  from  the  oriﬁce.  Three  plas-
ic  8.5F  double-pigtail  stents,  7--12  cm  in  length  between
aps,  and  a nasocystic  catheter  were  placed  inside  the
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ollection  (Fig.  1c).  Subsequent  saline  lavage  was  done
2000  cc/24  h).  An  ERCP  was  performed  on  a  second  endo-
copic  session  three  days  later,  and  despite  no  pancreatic
uct  leakage  was  seen,  a  decompressing  sphincterotomy  was
one.  The  patient  underwent  three  similar  endoscopic  ses-
ions  at  days  D8,  D28  and  D35  with  pneumatic  dilations  of
he  gastrocystic  oriﬁce  (maximal  diameter  15  mm)  plus  stent
ubstitution  until  clear  non-purulent  ﬂuid  was  seen  drain-
ng  out  from  the  cavity.  Follow-up  CT-scans  and  ﬂuoroscopy
uring  endoscopic  procedures  conﬁrmed  the  progressive
hrinking  of  the  collection  until  it  completely  disappeared.
his  was  accompanied  by  excellent  clinical  and  analytical
esponse.
Case  2:  A  48-year-old  female  developed  a  post-ERCP
evere  acute  necrotizing  pancreatitis.  After  initial  mana-
ement  with  conservative  therapy  during  the  ﬁrst  four
eeks,  she  suffered  clinical  deterioration  with  fever,  per-
istent  epigastric  abdominal  pain,  and  intolerance  to  oral
eeding  with  a palpable  mass  in  the  epigastrium.  Labo-
atory  data  were  also  consistent  with  clinical  worsening:
eucocytes  28.7  × 103/L,  haemoglobin  10.1  g/dL,  platelets
72  × 103/L,  INR  1.15,  C-reactive  protein  21.9  mg/dL,  BUN
4  mg/dL,  creatinine  0.75  mg/dL,  albumin  3.2  g/dL,  lactate
ehydrogenase  154  U/L,  alanine  aminotransferase  10  U/L,
spartate  aminotransferase  16  U/L,  alkaline  phosphatase
16  U/L,  gamma-glutamyltransferase  99  U/L,  total  bilirubin
.4  mg/dL,  amylase  115  U/L.
A  CECT-scan  visualized  peripancreatic  fat  densiﬁcation
nd  numerous  communicating  and  conﬂuent  peripancreatic
ollections,  extending  inferiorly,  with  11  cm  × 6.6  cm  in  size
Fig.  2a).
After  patient  consent,  we  decided  to  do  a  translu-
inal  endoscopic  drainage  under  anaesthetic  sedation.
 frank  bulging  on  the  lesser  curvature  of  the  gas-
ric  antrum  enabled  a direct  gastrocystostomy  with  a
re-cut  needle  (Wilson-Cook  Medical  Inc.®) and  place-
ent  of  a  standard  0.035-in.  guidewire  (Olympus®),  after
hich  balloon  dilation  (Olympus®)  of  the  entry  site  to
5  mm  was  done.  The  next  step  was  access  to  the  cavity
ith  a  Roth  net  (US  Endoscopy®)  which  allowed  extrac-
ion  of  large  amount  of  solid  brown  necrotic  debris
Fig.  2b).  Three  double-pigtail  plastic  stents,  7--8.5F,
--12  cm  in  length  between  ﬂaps,  plus  a  nasocystic  catheter
or  vigorous  washing  were  inserted  into  the  collec-
ion  (2500  cc/24  h).  A  multi-resistant  Escherichia  coli  was
solated  from  purulent  material  obtained  for  bacterial
ultures.
We  repeated  three  more  endoscopic  sessions  at  days  D6,
15  and  D35  since  the  ﬁrst  procedure.  Since  no  further  evi-
ence  of  ﬂuid  drainage  was  seen  during  the  last  procedure,
he  stents  were  deﬁnitely  removed  and  endoscopic  treat-
ent  sessions  were  ended.
A  CT-scan  only  detected  a  small  liquid  collection  of
.7  cm  × 2.9  cm,  between  the  gastric  antrum  and  the  pan-
reas.
igure  1  (a)  CT-scan  shows  a  large  abdominal  collection  with
olid debris.  (b)  Pneumatic  dilation  of  a  gastrocystic  hole  after
eedle knife  opening.  (c)  Stents  inside  the  collection  with
carce yellow  solid  debris  coming  out  from  the  cavity.
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dFigure  2  (a)  Peripancreatic  necrotic  collection  (arrow).  (b)
Thick necrotic  material  retrieved  from  WOPN  with  a  Roth  net.
Laboratory  data  after  last  treatment  was:  leuco-
cytes  6.2  ×  103/L,  haemoglobin  11.4  g/dL,  platelets
303  ×  103/L,  C-reactive  protein  1.29  mg/dL,  albu-
min  3.9  g/dL,  lactate  dehydrogenase  160  U/L,  alanine
aminotransferase  29  U/L,  aspartate  aminotransferase
26  U/L,  alkaline  phosphatase  148  U/L,  gamma-
glutamyltransferase  203  U/L,  total  bilirrubin  0.4  mg/dL,
amylase  130  U/L.
Clinical  outcome  after  follow-up  was  favourable.  On  the
last  appointment,  the  patient  felt  no  pain,  was  tolerating
normal  oral  feeding  and  had  gained  weight.
DiscussionIt  is  of  major  importance  to  clearly  establish  the  nature
of  a  collection  after  acute  necrotizing  pancreatitis.  A
sterile  asymptomatic  necrotic  collection  can  be  managed
t
f
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onservatively.1,8 On  the  other  hand,  an  infected  or  highly
ymptomatic  peripancreatic  necrotic  collection  merits  a
ore  aggressive  approach  because  stopping  the  infectious
rocess  is  crucial  for  the  formation  of  granulation  tissue.1--10
lassic  management  has  been,  for  decades,  open  necrosec-
omy  followed  by  postoperative  drainage.2,5,9,10
The  advent  of  new  endoscopic  techniques  for  the  past
wenty  years,  altogether  with  the  considerable  negative
utcomes  of  open  necrosectomy  have  been  the  main  reasons
hy  management  of  these  serious  complications  has  shifted.
ercutaneous  access  was  the  ﬁrst  approach  but,  soon  after,
ransluminal  access  with  an  endoscope  started  to  take  over
ith  compelling  results.2,4
Endoscopic  drainage  of  necrotic  peripancreatic  collec-
ions  has  historically  evolved  from  stents  and  nasobiliary
atheters  to  the  more  recent  direct  retroperitoneal
ebridement.7,9 This  happened  because  thick  necrotic
aterial  may  urge  the  need  for  additional  transluminal
ecrosectomy,  given  that  standard  7--10F  stents  may  be
nsufﬁcient  for  solid  necrotic  material  elimination.1,2,4--9
ome  authors  initially  argued  that  endoscopic  ultrasound
EUS)  should  be  used  to  assist  draining  procedures,  but
ecent  series  do  not  report  different  outcomes  in  terms  of
fﬁciency  or  adverse  events  without  the  use  of  EUS  given
hat  a clearly  visible  gastric  or  duodenal  bulge  exists.1,2,6 We
id  not  use  EUS  in  our  patients  because  an  evident  luminal
ompression  was  seen  in  both.
It  is  prudent  to  postpone  endoscopic  drainage  and
ebridement  for  some  weeks  after  onset  of  pancre-
titis  because  this  enhances  a  better  demarcation  of
ecrotic  tissue  from  the  viable  pancreas,  thus  avoid-
ng  unnecessary  risks.5,8 This  was  our  attitude  in  both
ases  and  it  is  unanimously  supported  from  published
xperiences.4,6,7
We  had  no  signiﬁcant  complications  but  multiple  sessions
ere  needed  to  deﬁnitively  achieve  complete  evacuation  of
ecrotic  material.  In  the  ﬁrst  case,  there  was  not  much  solid
aterial  and  therefore  our  strategy  was  to  maintain  stents
nd  a nasobiliary  catheter  with  intense  saline  lavage  rather
han  doing  necrosectomy.  Conversely,  the  second  patient
ad  signiﬁcant  amount  of  thick  solid  material  thus  demand-
ng  aggressive  debridement.
Limitations  of  endoscopic  necrosectomy  are  the  need  for
ultiple  sessions,  endoscopic  complications  (e.g.  perfora-
ion,  bleeding,  air  embolism)  and  the  lack  of  efﬁcacy  in  large
ollections  extending  far  away  from  the  transluminal  access
oint  into  the  pelvis.1,4--6,8 Furthermore  the  experience  of
he  endoscopist  is  of  paramount  importance.
Moreover,  the  lack  of  available  speciﬁc  endoscopic
evices  to  retrieve  necrotized  material  from  a  cavity  is
 relative  restraint.  Endoscopists  have  been  improvising
ith  ERCP  and  EUS  equipment  to  overtake  this  problem.1
anufacturers  are  expected  to  design  novel  tools  which
ay  possibly  reduce  the  number  of  endoscopic  sessions
er  patient  whilst  making  the  procedure  simpler.  An  even-
ually  useful  tool  might  be  a  removable  metallic  stent
laced  in  the  gastro/enterocystostomy  to  allow  easier
rainage.1
Advantages  of  endoscopic  intervention  are  considered
o  be  its  less  invasiveness,  fewer  days  of  hospitalizations,
aster  recovery,  less  organ  failure  and  secondary  infections
nd  better  aesthetic  outcomes.1,4,6,8 All  these  arguments
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10  
re  still  certainly  a  matter  of  debate  however,  taking  into
ccount  the  lack  of  prospective  randomized  trials.
Considering  our  experience,  we  believe  that  a  turn-
ng  point  in  the  management  of  peripancreatic  infected
nd/or  symptomatic  necrotic  collections  has  arrived.  Endo-
copic  transluminal  necrosectomy  will  probably  expand  as
n  alternative  method  to  classic  surgery.  Nevertheless,  this
resumption  is  expected  to  occur  in  large  tertiary  hospitals
ince  only  these  health-structures  can  more  easily  gather  a
ultidisciplinary  task  force  and  high  number  of  patients  to
ear  large  experience.
It  seems  reasonable  to  consider  a  step-up  algorithm
f  treatment  from  conservative  measures  to  endoscopic
ecrosectomy  and  ultimately  surgery.  Santvoort  et  al.
ustain  that  by  adopting  this  strategy,  as  much  as  35%
f  patients  can  avoid  surgery  and  total  treatment  costs
ecrease  12%  for  each  patient.5 Selecting  patients  to  one
r  another  therapeutic  technique  has  to  be  more  clearly
eﬁned.  Double-blind  prospective  randomized  trials  with
omogenous  patient  population  and  long  term  follow-up
re  required,  although  we  assume  this  will  be  very  hard  to
chieve.  This  could  help  reducing  selection  bias  from  previ-
us  published  series.  It  is  reasonable  to  assume  that  worst
atients  more  easily  undergo  laparotomy  directly  whilst
ess  ill  patients  can  be  selected  to  undergo  endotherapy
rstly.1,4,5,8 As  a  consequence  of  this  bias,  mortality  and  mor-
idity  outcomes  are  naturally  expected  to  differ  when  we
ompare  both  options.
In  conclusion,  necrotic  pancreatic  collections  are  hard  to
anage  and  have  an  important  impact  on  patient’s  survival
nd  health  costs.  New  strategies  have  been  being  developed
or  alternative  management  including  endotherapy,  which  is
t  the  front  line  of  investigation  and  practical  applicability.onﬂicts of interest
he  authors  have  no  conﬂicts  of  interest  to  declare.B.  Arroja  et  al.
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